Liontrust Investment Partners LLP Reduces Stock Holdings in Clarivate Plc (NYSE:CLVT)

Liontrust Investment Partners LLP lowered its stake in shares of Clarivate Plc (NYSE:CLVTFree Report) by 81.8% in the third quarter, HoldingsChannel reports. The firm owned 69,700 shares of the company’s stock after selling 313,308 shares during the quarter. Liontrust Investment Partners LLP’s holdings in Clarivate were worth $468,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in CLVT. US Bancorp DE boosted its position in Clarivate by 5.6% during the 1st quarter. US Bancorp DE now owns 14,343 shares of the company’s stock worth $240,000 after acquiring an additional 765 shares during the period. HighTower Advisors LLC lifted its holdings in shares of Clarivate by 19.1% in the first quarter. HighTower Advisors LLC now owns 98,518 shares of the company’s stock valued at $1,656,000 after buying an additional 15,785 shares during the period. Private Advisor Group LLC acquired a new stake in shares of Clarivate in the first quarter valued at $191,000. AlphaCrest Capital Management LLC lifted its holdings in shares of Clarivate by 47.7% in the first quarter. AlphaCrest Capital Management LLC now owns 25,536 shares of the company’s stock valued at $428,000 after buying an additional 8,243 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Clarivate in the first quarter valued at $204,000. Institutional investors and hedge funds own 86.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Jefferies Financial Group upgraded Clarivate from a “hold” rating to a “buy” rating and cut their price objective for the company from $10.00 to $8.50 in a report on Monday, October 16th. Wells Fargo & Company reaffirmed an “underweight” rating and set a $8.00 target price on shares of Clarivate in a research report on Friday, December 15th. Finally, Oppenheimer boosted their target price on Clarivate from $10.00 to $11.00 and gave the stock an “outperform” rating in a research report on Monday, January 8th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $8.33.

Get Our Latest Analysis on Clarivate

Clarivate Stock Up 1.3 %

NYSE:CLVT opened at $9.42 on Friday. The firm has a market capitalization of $6.25 billion, a price-to-earnings ratio of 36.23, a PEG ratio of 1.34 and a beta of 1.32. Clarivate Plc has a 1-year low of $6.07 and a 1-year high of $11.99. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.92. The business’s fifty day moving average price is $8.90 and its 200 day moving average price is $7.76.

About Clarivate

(Free Report)

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property.

Read More

Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVTFree Report).

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.